These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Recent biochemical developments with monoamine oxidase inhibitors. SHORE PA Dis Nerv Syst; 1960 Mar; 21(3)Suppl():62-3. PubMed ID: 14446179 [No Abstract] [Full Text] [Related]
25. [Monoamine oxidase inhibitors--a new group of drugs?]. NAESS K Nord Med; 1959 Aug; 62():1251-5. PubMed ID: 14425748 [No Abstract] [Full Text] [Related]
26. Structure and activity relationships of monoamine oxidase inhibitors. BIEL JH; NUHFER PA; CONWAY AC Ann N Y Acad Sci; 1959 Sep; 80():568-82. PubMed ID: 13800538 [No Abstract] [Full Text] [Related]
27. The interaction between reversible and irreversible monoamine oxidase inhibitors. HORITA A; McGRATH WR Biochem Pharmacol; 1960 Jun; 3():206-11. PubMed ID: 14403109 [No Abstract] [Full Text] [Related]
28. Behavioral determination of time and dose parameters of monoamine oxidase inhibitors. HEISE GA; BOFF E J Pharmacol Exp Ther; 1960 Jun; 129():155-62. PubMed ID: 14400778 [No Abstract] [Full Text] [Related]
29. Clinical and pharmacological considerations on mode of action of monoamine oxidase inhibitors. ZBINDEN G; RANDALL LO; MOE RA Dis Nerv Syst; 1960 Mar; 21(3)Suppl():89-100. PubMed ID: 13855472 [No Abstract] [Full Text] [Related]
30. Cardiac activities of several monoamine oxidase inhibitors. LEE WC; SHIN WH; SHIDEMAN FE J Pharmacol Exp Ther; 1961 Aug; 133():180-5. PubMed ID: 13760280 [No Abstract] [Full Text] [Related]
31. The pharmacological evaluation of monoamine oxidase inhibitors. LESSIN AW Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030 [No Abstract] [Full Text] [Related]
32. On the reported inhibition of monoamine oxidase by an agent with sedative properties. SPECTOR S; SHORE PA; BRODIE BB Science; 1960 Sep; 132(3429):735. PubMed ID: 13833206 [TBL] [Abstract][Full Text] [Related]
33. Anticonvulsant properties of monoamine oxidase inhibitors. PROCKOP DJ; SHORE PA; BRODIE BB Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994 [No Abstract] [Full Text] [Related]
37. Clinical toxicity studies of a monoamine oxidase inhibitor. GREENBLATT IJ; KAHN A Ann N Y Acad Sci; 1959 Sep; 80():947-59. PubMed ID: 13851575 [No Abstract] [Full Text] [Related]
38. A monoamine oxidase inhibitor in the treatment of organic disease. MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597 [No Abstract] [Full Text] [Related]
39. Monoamine oxidase inhibitors and procedures for their evaluation in vivo and in vitro. OZAKI M; WEISSBACH H; OZAKI A; WITKOP B; UDENFRIEND S J Med Pharm Chem; 1960 Dec; 2():591-607. PubMed ID: 13731832 [No Abstract] [Full Text] [Related]
40. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. BRODIE BB; SPECTOR S; SHORE PA Ann N Y Acad Sci; 1959 Sep; 80():609-16. PubMed ID: 13804624 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]